Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.
Journal of Nuclear Medicine November 2015 Tal Burt, Douglas C Rouse, Kihak Lee et al.
Intraarterial microdosing (IAM) is a novel drug development approach combining intraarterial drug delivery and microdosing. We aimed to demonstrate that IAM leads to target exposure similar to that of systemic full-dose administration but with minimal systemic exposure. IAM could enable the safe, inexpensive, and early study of novel drugs at the first-in-human stage and the study of...
DOI: 10.2967/jnumed.115.160986 (opens in new tab)
Full text (opens in new tab)
Microdosing
PET Imaging
Drug development
Intra-arterial